EUVIMEDEUVIMED entdecken
Crossref

Efficient Artificial T Cell Therapy for Bacterial‐Colonized Tumors

Shiyu Zhang, Han Zhu, Xintao Peng, Yang Zhou, Rentang Huang, Yi-Fan Wang, Shu-Lin Liu iD, Zhi-Gang Wang

Advanced Materials · 2025

DOI: 10.1002/adma.202503087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Shiyu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecul…. Hauptthemen laut MEDLINE: Neoplasms, T-Lymphocytes, Artificial Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Tianjin Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐colonizing bacteria can impede the efficacy of cancer treatments and elevate the risk of metastatic spread. While cytotoxic T lymphocytes (CTLs) are essential for destroying tumor cells, they lack the ability to eliminate bacteria. Here, the artificial T cells (ATC) are presented for tumors, particularly those colonized with intracellular bacteria. The ATC is composed of a hydrogel framework made of disulfide‐linked chitosan and hyaluronic acid, encapsulating T cell‐derived granzyme B and phage‐derived holin. This design leverages the tumor microenvironment for the targeted release of these antitumor and antibacterial agents to precisely kill tumor cells and intracellular bacteria. In vivo studies demonstrate the debris from ATC‐mediated destruction acts as an immune stimulator, promoting immune cell infiltration and inhibiting tumor migration. This work highlights the potential of ATC therapy in achieving targeted treatment and robust anti‐tumor immunity, advancing the field of artificial cell technologies for precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsT-LymphocytesArtificial CellsAnimalsHumansMiceCell Line, TumorChitosanHydrogelsTumor MicroenvironmentGranzymesAnti-Bacterial AgentsHyaluronic AcidAntineoplastic AgentsT-Lymphocytes, Cytotoxic

Stichwörter der Autor:innen

artificial T cellsbacteriophage holinhydrogel microcapsulessmart‐responsivetumor intracellular bacteria

Substanzen

ChitosanHydrogelsGranzymesAnti-Bacterial AgentsHyaluronic AcidAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical Sciences, College of Ch…

ORCID-Profile: Shu-Lin Liu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Tianjin Natural Science Foundation
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Zhang, S., Zhu, H., Peng, X., Zhou, Y., Huang, R., Wang, Y. F., Liu, S. L., & Wang, Z. G. (2025). Efficient Artificial T Cell Therapy for Bacterial‐Colonized Tumors. Advanced Materials. https://doi.org/10.1002/adma.202503087

Vancouver

Zhang S, Zhu H, Peng X, Zhou Y, Huang R, Wang YF, et al. Efficient Artificial T Cell Therapy for Bacterial‐Colonized Tumors. Advanced Materials. 2025. doi:10.1002/adma.202503087

BibTeX
@article{Zhang2025,
  author = {Zhang, Shiyu and Zhu, Han and Peng, Xintao and Zhou, Yang and Huang, Rentang and Wang, Yi-Fan and Liu, Shu-Lin and Wang, Zhi-Gang},
  title = {Efficient Artificial T Cell Therapy for Bacterial‐Colonized Tumors},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202503087}
}
Kostenlos starten →